Rates of Toxicity and Outcomes After Mediastinal Proton Therapy For Relapsed/Refractory Lymphoma

Authors :: A. Maity
Carlos Vargas
Nancy P. Mendenhall
David Miller
S. Flampouri
Ronica H. Nanda
John P. Plastaras
Yolanda D. Tseng
William F. Hartsell
Pranshu Mohindra
Bradford S. Hoppe
Source :: International Journal of Radiation Oncology*Biology*Physics. 99:S62-S63
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: 0301 basic medicine
Oncology
Cancer Research
medicine.medical_specialty
Radiation
business.industry
medicine.disease
Lymphoma
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
Toxicity
Relapsed refractory
Medicine
Radiology, Nuclear Medicine and imaging
business
Proton therapy

Full Text Access

Tools